Expanding Our Reach
The medicinal and recreational cannabis landscape around the world is rapidly evolving, presenting a tremendous opportunity in gaining market share. LUFT is currently in the process of obtaining a pharmaceuticals license in Portugal.
Portugal Distribution Facility
Access to International / EU Market
LUFT’s pharmaceutical license will allow distribution in Portugal and export to other European countries. The facility is projected to open in Q1 2020.
LUFT’s Canadian facility and procedures have been developed to EU GMP (Good Manufacturing Practice) Guidelines, a prerequisite for the sale of any pharmaceuticals into any countries in the EU and the EEA.
The EU population exceeds 500 million which allows LUFT to diversify across global markets as part of our long-term growth plan.